Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Combination Product: ofatumumab with AI[1] Ofatumumab[1] Ofatumumab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13 💬
2Combination Product: ofatumumab with PRF[1] Ofatumumab[1] Ofatumumab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13 💬
3Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab[12] Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide		[10] Cladribine ,
Alemtuzumab ,
Rituximab ,
Dimethyl fumarate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab ,
Fingolimod ,
Teriflunomide ,
Ponesimod 💬		[7] CD52,
DHODH,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬		[30] Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬[1] 13 💬
4OFATUMUMAB[1] Ofatumumab[1] Ofatumumab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[3] 13, 35, 46 💬
5Ofatumumab 100[1] Ofatumumab[1] Ofatumumab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13 💬
6Ofatumumab 300[1] Ofatumumab[1] Ofatumumab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13 💬
7Ofatumumab 30mg[1] Ofatumumab[1] Ofatumumab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13 💬
8Ofatumumab 3mg[1] Ofatumumab[1] Ofatumumab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13 💬
9Ofatumumab 60mg[1] Ofatumumab[1] Ofatumumab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13 💬
10Ofatumumab 700[1] Ofatumumab[1] Ofatumumab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13 💬
11Ofatumumab subcutaneous injection[1] Ofatumumab[1] Ofatumumab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13 💬